Out-licensing creates an opportunity for the companies to develop their portfolio, to gain massive and rapid ROI. Aconitum developed 4 valuable CTD out-licensing products, and we are also open to explore out-licensing for our products in different territories.
|Substance, strength||Form||Dossier type||Registration status|
|Silymarin 140 mg (from Milk thistle (Silybum marianum) extract)||hard capsules||Bibliographic||Registered in Lithuania, Vietnam|
|Vinpocetine 5 mg / 10 mg||tablet||Bibliographic||Registered in Lithuania, Vietnam, Bulgaria, Bosnia and Herzegovina, Serbia|
|Vinpocetine 5 mg / 10 mg||hard capsules||Bibliographic||Registered in Lithuania|
|Ginkgo extract (Ginkgo biloba) 80 mg / 120 mg||hard capsules||Bibliographic||Registered in Lithuania, Vietnam|